Meritain Eldorado policies, page 99

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Eldorado, by title.

Meritain Eldorado policies
PolicyDetailsCodesSource
Hematopoietic Colony-Stimulating Factors (CSFs)0055 · Commercial91Original policy ↗
Hemodialysis for Schizophrenia0291 · Commercial3Original policy ↗
Hepatitis B Vaccine0410 · Commercial5Original policy ↗
Hereditary Angioedema0782 · Commercial14Original policy ↗
Herpes Simplex Virus - Screening and Diagnosis0433 · Commercial9Original policy ↗
Hip Arthroplasty0287 · Commercial33Original policy ↗
Hip Preservation Surgery0736 · Commercial22Original policy ↗
Histamine Desensitization Therapy for Intractable Headaches0647 · Commercial2Original policy ↗
HIV Drug Susceptibility and Resistance Tests0316 · Commercial8Original policy ↗
HIV Testing0542 · Commercial16Original policy ↗
Holter Monitors0019 · Commercial4Original policy ↗
Home Births0329 · Commercial17Original policy ↗
Home Cholesterol Monitors0367 · Commercial1Original policy ↗
Home Health Aides0218 · Commercial31Original policy ↗
Home/Ambulatory Spirometry0572 · Commercial6Original policy ↗
Homocysteine Testing0763 · Commercial3Original policy ↗
Hospital Beds and Accessories0543 · Commercial61Original policy ↗
Human Fibrinogen Concentrate Products0792 · Commercial49Original policy ↗
Humira and Biosimilars SGM 2008-A P2024a2008-A P2024a · Commercial—Original policy ↗
Huntington's Disease0614 · Commercial60Original policy ↗
Hycamtin capsules 1659-A SGM P20241659-A · Commercial—Original policy ↗
hydroxyprogesterone caproate-Makena 1780-A SGM P20211780-A · Commercial—Original policy ↗
Hyperhidrosis0504 · Commercial26Original policy ↗
Hypertensive Disorders of Pregnancy0368 · Commercial4Original policy ↗
Hyperthermia in Cancer Therapy0278 · Commercial13Original policy ↗
Hypertrophic Scars and Keloids0389 · Commercial56Original policy ↗
Ibrance 1726-A SGM P20231726-A · Commercial—Original policy ↗
icatibant-Sajazir-Firazyr SGM 1606-A P2024b_R1606-A · Commercial—Original policy ↗
Iclusig 2173-A SGM P20242173-A · Commercial—Original policy ↗
Idiopathic Scoliosis0398 · Commercial77Original policy ↗
Ilumya SGM 2538-A P20262538-A · Commercial—Original policy ↗
Implantable Hormone Pellets0345 · Commercial9Original policy ↗
Infertility0327 · Commercial323Original policy ↗
Infliximab0341 · Commercial92Original policy ↗
infliximab-Remicade and Biosimilars SGM 2182-A P2024a2182-A · Commercial—Original policy ↗
Influenza Rapid Diagnostic Tests0476 · Commercial10Original policy ↗
Influenza Treatment and Prevention Post Limit PA Policy 111-J UDR 09-2023 v2111-J · Commercial—Original policy ↗
Influenza Vaccines0035 · Commercial55Original policy ↗
Infrared Therapy0604 · Commercial4Original policy ↗
Ingrezza 1750-A SGM P20221750-A · Commercial—Original policy ↗
Ingrezza 1750-A SGM P20221750-A · Commercial—Original policy ↗
Ingrezza 1750-A SGM P20241750-A · Commercial—Original policy ↗
Injectable Medications0020 · Commercial64Original policy ↗
Inqovi SGM 4002-A P2026a4002-A P2026a · Commercial—Original policy ↗
Insomnia (Edluar, Intermezzo, Zolpimist) PA with Limit Policy 387-C 04-2021387-C · Commercial—Original policy ↗
Intensity Modulated Radiation Therapy0590 · Commercial12Original policy ↗
Intensive Cardiac Rehabilitation Programs0267 · Commercial36Original policy ↗
Interferons0404 · Commercial6Original policy ↗
Intermittent Pneumatic Compression Devices0500 · Commercial25Original policy ↗
Intervertebral Disc Prostheses0591 · Commercial28Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.